United Kingdom

Our contribution to UK healthcare

Our generic medicines help drive sustainability and value
 We’re focusing on the conditions that impact high numbers of patients and drive costs up Joint Working with the NHS Patient groups and UK charities The future for Teva medicines

Millions of patients throughout the UK benefit from our medicines.

We’re a proactive company employing proactive people, so we’re actively involved with industry trade associations, healthcare professional forums and patient groups.

This means that we always seek to be at the forefront when it comes to driving the UK healthcare agenda.

Our generic medicines help drive sustainability and value

The NHS is going through the biggest financial squeeze in its history. The increasing demand for care, driven by a growing and aging population, means that services are under huge pressure. It is estimated that there will be a £30 billion shortfall per year by 2020/21.1

It is because of this challenging environment that we are working hard to help the NHS do more with less so funds can be freed up to allow patients to continue to access the care and treatment they need.

More than two-thirds of the medicines dispensed by the NHS are generics, yet they cost less than one third of the NHS drugs bill.Generic medicines save the NHS more than £13 billion in just England and Wales.3



We’re focusing on the conditions that impact high numbers of patients and drive costs up

An aging population, changing patterns of disease and rising patient expectations will all add to the demands on the NHS. There is now wide consensus we need to do more to focus on those diseases that are impacting high numbers of patients and driving up costs.

We are focused on these disease areas where we are making a real difference – respiratory conditions such as asthma, Cystic Fibrosis and Chronic Obstructive Pulmonary Disease (COPD), and disorders of the central nervous system and pain management.

Alongside these projects, we are continuing to invest millions every year in UK-based clinical trials to look at how we can do even more to help patients in a wide variety of disease areas.


Joint working with the NHS

We have joint working partnerships around the country to help support the NHS and the Department of Health in making a real difference to the health of patients in the UK.

Here are a few examples of the work we are doing in this area:

  • Bristol Clinical Commissioning Group: to improve asthma education and achieve better asthma control for people in the city’s Somali community
  • Ashford Clinical Commissioning Group: collaborative project between pharmacy and surgery to improve the education and experience of asthma patients in surgery and pharmacy
  • Wirral Health Commissioning Consortia: to ultimately improve the clinical management of asthma and therefore the outcomes for patients with asthma over the age of twelve within participating practices.

More about our joint working with the NHS >


Patient groups and UK charities

With such a broad range of therapy areas covered by our medicines range, we also have links with a number of charities and patient organisations. We understand the values and role these important organisations play in supporting not only patients, but also their relatives and carers.

As patients and caregivers become more knowledgeable and proactive in treatment decisions, they can provide vital insights on the acceptance and use of health-related products and services. Engaging patients can improve quality of care, patient satisfaction, and health outcomes, while also reducing medical error and healthcare costs. 

We work with patient advocacy organizations around the world to advance our understanding of patient needs, amplify the patient voice within our company, and ultimately support patients who require specific solutions and assistance. More than ever, we value our relationships with these organizations and our shared commitment to helping patients and caregivers on their journeys to improved health and better lives.

Our nominated charity is International Health Partners, which is dedicated to improving access to healthcare and medicines in the developing world. You can learn more about our Corporate Social Responsibility work in Our Responsibility.


The future for Teva medicines

Going forward people want to feel able to manage their health just as they manage other aspects of their lives. Being proactive, in the know, and understanding the 'why', 'what' and 'how' of what’s happening to them creates a positive mind-set and provides a feeling of greater control. 

As people seek to play a bigger role in their health, we too must play a bigger role in enabling them to feel more in control by providing both emotional and functional support in the form of the medicines, tools and information they need. 

And it doesn’t stop there. We’re also actively researching new uses for existing medicines – either by changing formulation, delivery or use to address a specific unmet patient need.

You can learn more about our medicines and our research into new medicines in Our Medicines.



[1] Five Year Forward View – NHS England - https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf#page=37 – last accessed 06/08/2019

[2] British Generics Manufacturers Association – About us.http://www.britishgenerics.co.uk/about-generics -  last accessed 18/02/2019

[3] NHS costs to soar as drugs become more complex - The Times - https://www.thetimes.co.uk/article/nhs-costs-to-soar-as-drugs-become-more-complex-z2688zz3w8t - last accessed 06/08/2019

Teva Ref: WN701